Skip to main content

Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs

Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs
By Christina Jewett from NYT Health https://ift.tt/4jFBvZg
United States International Relations, Drugs (Pharmaceuticals), Factories and Manufacturing, United States Politics and Government, Biotechnology and Bioengineering, Cystic Fibrosis, Cancer, Supply Chain, Intellectual Property, Shortages, Government Contracts and Procurement, Labor and Jobs, Start-ups, Leukemia, Research, Tax Credits, Deductions and Exemptions, AbbVie Inc, Eli Lilly and Company, GlaxoSmithKline PLC, House of Representatives, Janssen Pharmaceutica, People's Liberation Army (China), Senate, WuXi PharmaTech, China, Delaware, Massachusetts
Labels:

Comments

Post a Comment

Popular posts from this blog

Why the Software Development Tools you Choose Directly Affect Your CI/CD Reliability 

Most conversations about CI/CD reliability start in the wrong place. Teams debug flaky pipelines, investigate intermittent failures, tune alerting thresholds and optimize build times. All of that work is legitimate. However, the decisions that most directly determine whether a CI/CD pipeline is reliable or not were made months or years earlier, during tool selection. By the time teams are debugging pipeline reliability, they are usually dealing with the downstream consequences of upstream decisions that seemed reasonable at the time.   The software development tools a team chooses shape their CI/CD pipeline in ways that are not always visible during evaluation. Understanding those connections is the most practical starting point for teams that want reliable pipelines rather than better pipeline firefighting.   The Integration Surface Problem   Every tool in a software development stack creates an integration surface. Integration surface is the set of connections a tool has with oth...
Post a Comment
Read more

They Survived Covid. Now They Need New Lungs.

They Survived Covid. Now They Need New Lungs. By Daniela J. Lamas from NYT Opinion https://ift.tt/3aQtonL Transplants, Lungs, Coronavirus (2019-nCoV), Hospitals
Post a Comment
Read more